文献速递肺外科

扩展袖状肺叶切除术治疗中心型非小细胞肺癌的手术结局

Surgical Outcome After Extended Sleeve Lobectomy in Centrally Located Non-small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2022-04-06

该回顾性研究纳入119例中心型非小细胞肺癌患者,其中43例接受扩展袖状肺叶切除术(ESL),76例接受全肺切除术(PN)。ESL术后30天住院死亡1例(2.3%),≥3级并发症13例(30%)。ESL组3年总生存率显著优于PN组(62.8% vs 45.2%,P = .047)。作者认为,在适当选择的中心型非小细胞肺癌患者中,保留肺实质的ESL可能成为有前景的手术策略。

要点

  • ESL术后30天住院死亡1例(2.3%),≥3级并发症13例(30%)。
  • ESL术后支气管吻合口/残端瘘4例(9.3%),血栓所致血流灌注障碍4例(9.3%)。
  • ESL组3年总生存率62.8% vs PN组45.2%(P = .047)。

核心结论

  • 在适当选择的中心型非小细胞肺癌患者中,保留肺实质的扩展袖状肺叶切除术可能成为有前景的手术策略。

研究设计与样本

  • 回顾性综述纳入119例因中心型非小细胞肺癌接受肺切除术的患者,其中43例接受扩展袖状肺叶切除术(ESL),76例接受全肺切除术(PN)。
  • 术后并发症按不良事件通用术语标准5.0版评估,总生存采用Cox比例风险模型分析。

主要发现

  • ESL分型中,A型10例,B型8例(19%),C型16例(37%),D型9例(21%)。
  • 肺动脉重建在A型中5例、B型中8例、C型中1例、D型中1例;肺静脉重建在A型中3例、C型中2例。
  • ESL术后30天住院死亡1例(2.3%),≥3级并发症13例(30%)。
  • ESL术后支气管吻合口/残端瘘4例(9.3%),血栓所致血流灌注障碍4例(9.3%)。
  • ESL组3年总生存率62.8% vs PN组45.2%(P = .047),ESL组显著优于PN组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We primarily aimed to evaluate the operative techniques, clinicopathologic characteristics, and surgical outcomes after extended sleeve lobectomy (ESL). Additionally, we evaluated the feasibility of ESL for centrally located non-small cell lung cancer (NSCLC) compared with pneumonectomy (PN). METHODS: A retrospective review identified 119 patients who underwent pulmonary resections for centrally located NSCLC; of whom, 43 underwent ESLs and 76 underwent PNs. Perioperative morbidity and oncologic outcomes of ESL were analyzed. Postoperative morbidity was evaluated according to the Common Terminology Criteria for Adverse Events version 5.0. Overall survival was evaluated using a Cox proportional hazard model. RESULTS: According to the classifications of ESL, 10 patients comprised type A, 8 (19%) type B, 16 (37%) type C, and 9 (21%) type D. Pulmonary artery reconstructions were performed in 5 of type A, 8 of type B, 1 of type C, and 1 of type D, and pulmonary vein reconstructions occurred in 3 of type A and 2 of type C. After ESL, 30-day hospital mortality occurred in 1 patient (2.3%), and grade ≥3 morbidities occurred in 13 patients (30%). In particular, bronchial anastomosis/stump fistula was seen in 4 patients (9.3%) after ESL, and blood perfusion disorders due to the presence of thrombi were seen in 4 (9.3%). The 3-year overall survival was significantly better after ESL compared with that after PN (62.8% vs 45.2%, P = .047). CONCLUSIONS: ESLs to preserve lung parenchyma will likely become a promising operative strategy in appropriately selected patients with centrally located NSCLC.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hattori A, Matsunaga T, Fukui M, et al. Surgical Outcome After Extended Sleeve Lobectomy in Centrally Located Non-small Cell Lung Cancer. Ann Thorac Surg. 2022. PMID: 35398037. doi:10.1016/j.athoracsur.2022.02.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。